|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,8 Jahre
|
354,68 |
+17,62% |
+56,04% |
+19,19% |
-24,24% |
|
Abaris Biotechnology Opportunities
LU2210105313
USD / Acc. / Retail
|
30.10.2020
5,7 Jahre
|
8,04 |
+18,08% |
+82,48% |
+101,97% |
-0,76% |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
8,8 Jahre
|
935,51 |
+18,29% |
+59,69% |
+55,32% |
+34,77% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,7 Jahre
|
406,70 |
+18,31% |
+59,80% |
+55,37% |
+34,86% |
|
UBS (Lux) Equity Fund - Biotech (USD)
LU0069152568
USD / Acc. / Retail
|
15.10.1996
29,8 Jahre
|
450,23 |
+19,91% |
+62,56% |
+47,33% |
+28,75% |
|
LS ARK Genomic Revolution Tracker ETP Securities
XS2399368062
USD / Acc. / Retail
|
10.12.2021
4,6 Jahre
|
1,00 |
+20,17% |
+60,53% |
+16,42% |
N/A |
|
Pictet - Biotech
LU0090689299
USD / Acc. / Retail
|
30.11.1995
30,7 Jahre
|
2.072,89 |
+20,25% |
+87,76% |
+85,88% |
+62,39% |
|
WEALTHGATE Biotech Fund
DE000A3ETA12
USD / Dist. / Retail
|
14.02.2024
2,4 Jahre
|
5,28 |
+20,34% |
+76,91% |
N/A |
N/A |
|
Candriam Equities L Biotechnology
LU0108459040
USD / Acc. / Retail
|
06.04.2000
26,3 Jahre
|
1.737,85 |
+20,51% |
+74,91% |
+70,58% |
+75,42% |
|
Janus Henderson Horizon Biotechnology Fund
LU1897414303
USD / Acc. / Retail
|
10.12.2018
7,6 Jahre
|
1.751,54 |
+20,79% |
+87,62% |
+98,19% |
+120,21% |